Drug Profile
TF 0066
Alternative Names: TF 0066Latest Information Update: 05 Sep 2023
Price :
$50
*
At a glance
- Originator Techfields Pharma
- Class Analgesics; Antidepressants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Depressive disorders; Neuropathic pain
Most Recent Events
- 05 Sep 2023 TF 066 is still in preclinical trials for Depressive disorders in USA (Techfields Pharma pipeline, September 2023)
- 05 Sep 2023 TF 066 is still in preclinical trials for Neuropathic pain in USA (Techfields Pharma pipeline, September 2023)
- 07 Jul 2016 Preclinical trials in Neuropathic pain in USA (unspecified route)